MESENCHYMAL STEM CELLS: A REGENERATIVE HOPE FOR ALZHEIMER'S PATIENTS
Abstract
Alzheimer’s disease (AD) is a progressive neurodegenerative disorder characterized by cognitive decline, memory impairment, and neuronal loss. Despite extensive research, effective disease-modifying therapies remain limited. Mesenchymal stem cells (MSCs) have emerged as a promising therapeutic candidate due to their multipotent properties, immunomodulatory capacity, and ability to secrete neurotrophic factors. This review explores various aspects of AD, as well as it explores MSCs mechanisms of action including reduction of neuroinflammation, promotion of neurogenesis, clearance of amyloid-β plaques, and protection against oxidative stress. We also discuss the various sources of MSCs, and methods of delivery.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Chelonian Research Foundation

This work is licensed under a Creative Commons Attribution 4.0 International License.